Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Benefits in Diabetics With Cardiovascular Disease

Optimal blood glucose control helps reduce the development of the complications of type II diabetes mellitus (T2DM). T2DM patients usually are at increased risk of cardiovascular (CV) events and mortality. Therapies and strategies to treat diabetes and its related CV outcomes still need more investi...

Full description

Saved in:
Bibliographic Details
Published in:Cureus
Main Authors: Aftab, Saba, Vetrivel Suresh, Rishwanth, Sherali, Nazleen, Daniyal, Muhammad, Tsouklidis, Nicholas
Format: Artigo
Language:Inglês
Published: Cureus 2020
Subjects:
Internal Medicine
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535950/
https://ncbi.nlm.nih.gov/pubmed/33042651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10783
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items